For people with eczema, stress can trigger flare-ups and worsen their itchy rashes. But the link between stress and skin ...

Apogee Therapeutics has published phase 2 eczema data that suggest its anti-IL-13 antibody is a threat to Eli Lilly, ...

Apogee Therapeutics is advancing APG777, an experimental antibody designed to treat moderate-to-severe atopic dermatitis with far fewer injections than existing biologics. Early clinical data show the ...

Key Takeaways Eczema flare-ups may follow patterns scientists can predictEven small body changes can trigger big ...

An experimental treatment for eczema from Apogee Therapeutics induced skin and itch relief comparable to current, widely used ...

Company shares climbed by more than 20% on Phase 2 study results suggesting the therapy could provide sustained relief when ...

Anyone with a chronic illness understands the struggle of living with a disease that is deeply unpredictable. Many such ...

Eli Lilly scored $408 million in U.S. sales of eczema treatment Ebglyss in its first full year on the market in 2025. | With ...

MOH said it will provide an update when it is ready, with a decision expected to be made in 2026. Read more at ...

After battling eczema breakouts, a beauty writer shares how this new Fenty Beauty eyeliner made her believe in eye makeup again.